Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Mylan, Pfizer Appoint Viatris CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Mylan, Pfizer Appoint Viatris CFO

Upjohn's Sanjeev Narula brings global experience and leadership

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Mylan and Pfizer have appointed Sanjeev Narula, current chief financial officer of Upjohn, a division of Pfizer, as incoming CFO of Viatris, the new company that will result from the planned combination of Mylan and Upjohn. Expected to close mid-2020, Viatris will have a portfolio of approximately 3,000 brands and molecules and a commercial presence in 165 countries.

Mr. Narula spent 16 years with Pfizer serving in several financial leadership positions, and has worked under the leadership of Pfizer’s Chief Financial Officer and Executive Vice President of Business Operations and Global Supply, Frank D’Amelio. At Upjohn, he worked closely with incoming Viatris CEO Michael Goettler and has developed a deep understanding of financial and commercial dynamics across key geographies, including emerging markets, particularly China. He also brings knowledge of the generic and branded pharmaceutical business.

Pfizer Chairman and CEO Dr. Albert Bourla said: “Sanjeev’s global experience, proven leadership, and deep industry knowledge will serve Viatris employees, customers and shareholders well. I am very confident that his commitment to excellence will be instrumental as the new company charts its path as a champion for global health.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters